Kedudukan dalam Saham
#19830
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Perubahan (1 hari)
-1.39%
Perubahan (1 tahun)
24.38%
Perdagangan Alpha Cognition Inc (ACOG)
Harga ACOG dengan permodalan pasaran b
Modal pasaran bagi Alpha Cognition Inc(ACOG)
Modal Pasaran: $149.33M
Sehingga August 2026, Alpha Cognition Inc mempunyai modal pasaran sebanyak $149.33M. Ini menjadikan Alpha Cognition Inc syarikat ke-19830th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Alpha Cognition Inc dari 2024 hingga 2026
ACOG berbanding dengan 5 teratas yang paling popular stocks
| Harga ACOG |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.152T
|
+3,450,396.58%
|
|
|
|
|
$4.537T
|
+3,038,233.58%
|
|
|
|
|
$4.169T
|
+2,791,489.37%
|
|
|
|
|
$3.642T
|
+2,439,094.36%
|
|
|
|
|
$2.805T
|
+1,878,142.65%
|
